654 related articles for article (PubMed ID: 8322763)
41. Cost-effectiveness of Haemophilus influenzae type b (Hib) vaccine introduction in the universal immunization schedule in Haryana State, India.
Gupta M; Prinja S; Kumar R; Kaur M
Health Policy Plan; 2013 Jan; 28(1):51-61. PubMed ID: 22407018
[TBL] [Abstract][Full Text] [Related]
42. Impact of Haemophilus influenzae type b conjugate vaccination on hospitalization for invasive disease in children fifteen years after its introduction in Italy.
Martinelli D; Azzari C; Bonanni P; Esposito S; Franco E; Icardi G; Zuccotti G; Prato R
Vaccine; 2017 Nov; 35(46):6297-6301. PubMed ID: 28988865
[TBL] [Abstract][Full Text] [Related]
43. Effectiveness of the DTPa-HBV-IPV/Hib vaccine against invasive Haemophilus influenzae type b disease in the Netherlands (2003-16): a case-control study.
Monge S; Hahné SJ; de Melker HE; Sanders EA; van der Ende A; Knol MJ
Lancet Infect Dis; 2018 Jul; 18(7):749-757. PubMed ID: 29752131
[TBL] [Abstract][Full Text] [Related]
44. Burden of invasive disease caused by Haemophilus influenzae type b in Bamako, Mali: impetus for routine infant immunization with conjugate vaccine.
Sow SO; Diallo S; Campbell JD; Tapia MD; Keita T; Keita MM; Murray P; Kotloff KL; Levine MM
Pediatr Infect Dis J; 2005 Jun; 24(6):533-7. PubMed ID: 15933564
[TBL] [Abstract][Full Text] [Related]
45. National and provincial impact and cost-effectiveness of Haemophilus influenzae type b conjugate vaccine in China: a modeling analysis.
Zhang H; Garcia C; Yu W; Knoll MD; Lai X; Xu T; Jing R; Qin Y; Yin Z; Wahl B; Fang H
BMC Med; 2021 Aug; 19(1):181. PubMed ID: 34376214
[TBL] [Abstract][Full Text] [Related]
46. Cost-effectiveness of a potential vaccine candidate for Haemophilus influenzae serotype 'a'.
Shoukat A; Van Exan R; Moghadas SM
Vaccine; 2018 Mar; 36(12):1681-1688. PubMed ID: 29459062
[TBL] [Abstract][Full Text] [Related]
47. Pneumonia prevention: Cost-effectiveness analyses of two vaccines among refugee children aged under two years, Haemophilus influenzae type b-containing and pneumococcal conjugate vaccines, during a humanitarian emergency, Yida camp, South Sudan.
Gargano LM; Hajjeh R; Cookson ST
Vaccine; 2017 Jan; 35(3):435-442. PubMed ID: 27989625
[TBL] [Abstract][Full Text] [Related]
48. Efficacy and Prolonged Safety of
Tripathi N; Mukherjee S
Infect Disord Drug Targets; 2024; 24(5):e150124225640. PubMed ID: 38231056
[TBL] [Abstract][Full Text] [Related]
49. New vaccines against otitis media: projected benefits and cost-effectiveness.
O'Brien MA; Prosser LA; Paradise JL; Ray GT; Kulldorff M; Kurs-Lasky M; Hinrichsen VL; Mehta J; Colborn DK; Lieu TA
Pediatrics; 2009 Jun; 123(6):1452-63. PubMed ID: 19482754
[TBL] [Abstract][Full Text] [Related]
50. Haemophilus influenzae type b conjugate vaccines - a South African perspective.
Visser A; Hoosen A
Vaccine; 2012 Sep; 30 Suppl 3():C52-7. PubMed ID: 22939022
[TBL] [Abstract][Full Text] [Related]
51. Immunization with oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine on a large health maintenance organization population: extended follow-up and impact on Haemophilus influenzae disease epidemiology. The Kaiser Permanente Pediatric Vaccine Study Group.
Black SB; Shinefield HR
Pediatr Infect Dis J; 1992 Aug; 11(8):610-3. PubMed ID: 1523069
[TBL] [Abstract][Full Text] [Related]
52. High incidence of Haemophilus influenzae type b infection in children in Pacific island countries.
Russell FM; Carapetis JR; Mansoor O; Darcy A; Fakakovi T; Metai A; Potoi NT; Wilson N; Mulholland EK
Clin Infect Dis; 2003 Dec; 37(12):1593-9. PubMed ID: 14689337
[TBL] [Abstract][Full Text] [Related]
53. Immunization of US children with Hemophilus influenzae type b polysaccharide vaccine. A cost-effectiveness model of strategy assessment.
Cochi SL; Broome CV; Hightower AW
JAMA; 1985 Jan; 253(4):521-9. PubMed ID: 3918181
[TBL] [Abstract][Full Text] [Related]
54. Cost-effectiveness of Haemophilus influenzae type b vaccine in Vietnam.
Le P; Griffiths UK; Anh DD; Franzini L; Chan W; Swint JM
Vaccine; 2015 Aug; 33(36):4639-46. PubMed ID: 26044493
[TBL] [Abstract][Full Text] [Related]
55. Effectiveness of Haemophilus influenzae type B conjugate vaccine on prevention of pneumonia and meningitis in Bangladeshi children: a case-control study.
Baqui AH; El Arifeen S; Saha SK; Persson L; Zaman K; Gessner BD; Moulton LH; Black RE; Santosham M
Pediatr Infect Dis J; 2007 Jul; 26(7):565-71. PubMed ID: 17596795
[TBL] [Abstract][Full Text] [Related]
56. Haemophilus influenzae type b (Hib) vaccine: an effective control strategy in India.
Verma R; Khanna P; Chawla S; Bairwa M; Prinja S; Rajput M
Hum Vaccin; 2011 Nov; 7(11):1158-60. PubMed ID: 22048118
[TBL] [Abstract][Full Text] [Related]
57. [Invasive infections caused by Haemophilus influenzae type b after the institution of the conjugated vaccine on the expanded programm on immunization in Chile].
Cruces R P; Donoso F A; Camacho A J; Llorente H M
Rev Chilena Infectol; 2006 Mar; 23(1):50-4. PubMed ID: 16462964
[TBL] [Abstract][Full Text] [Related]
58. Defining the burden of pneumonia in children preventable by vaccination against Haemophilus influenzae type b.
Levine OS; Lagos R; Muñoz A; Villaroel J; Alvarez AM; Abrego P; Levine MM
Pediatr Infect Dis J; 1999 Dec; 18(12):1060-4. PubMed ID: 10608624
[TBL] [Abstract][Full Text] [Related]
59. Impact of Haemophilus influenzae type b (Hib) conjugate vaccines on Haemophilus influenzae meningitis in Wisconsin.
Enders PJ; Trepka MJ; Davis JP
WMJ; 2000 Aug; 99(5):45-8. PubMed ID: 11043070
[TBL] [Abstract][Full Text] [Related]
60. Foresight in medicine: current challenges with Haemophilus influenzae type b conjugate vaccines.
Eskola J
J Intern Med; 2010 Mar; 267(3):241-50. PubMed ID: 20201918
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
